News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Bejar Rafael
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/23/2023 |
4
| Bejar Rafael (Sr. VP, Chief Medical Officer) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Granted 100,000 shares
@ $0
Granted 200,000 options to buy
@ $0.66, valued at
$132k
|
|
| 01/20/2022 |
4
| Bejar Rafael (Sr. VP, Chief Medical Officer) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Granted 600,000 options to buy
@ $1.34, valued at
$804k
|
|
| 11/19/2021 |
4
| Bejar Rafael (Sr. VP, Chief Medical Officer) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Bought 10,000 shares
@ $2.56, valued at
$25.6k
|
|
| 08/23/2021 |
4
| Bejar Rafael (Sr. VP, Chief Medical Officer) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Granted 200,000 options to buy
@ $2.35, valued at
$470k
|
|
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2020 |
4
| Bejar Rafael (Sr. VP, Chief Medical Officer) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Granted 200,000 options to buy
@ $6.91, valued at
$1.4M
|
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|